Baby research challenged in new report Tue, Aug 23 2011 By Frederik Joelving NEW YORK (Reuters Health) - Tests of medical treatments in babies vary markedly in quality, at least as judged by the reports that make it into scientific journals, researchers say. That's a problem, they assert, because trials that don't follow rigorous scientific standards are more prone to bias that makes the results unreliable. Ultimately, those results trickle down into patient care, dictating what drugs and devices doctors use to help ailing children, said Dr. Sara B. DeMauro, of The Children's Hospital of Philadelphia, who worked on the findings. "There is always the possibility that the authors did do something and then forgot to report it, but that's less likely," she told Reuters Health. DeMauro and her colleagues rated 179 randomized controlled trials -- the "gold standard" study design -- published in six prestigious medical journals, including three that specialized in pediatric medicine and three general medical publications.
This is the end of the preview.
access the rest of the document.